At Phoenix Clinical Research, they take great pride in their commitment to delivering exceptional services, ensuring precision, and strict adherence to protocols through their unparalleled clinical trial monitoring expertise. Their efficient project management approach guarantees seamless coordination and timely execution of all trial aspects, setting them apart as a reliable partner. With a strong focus on excellence, integrity, and innovation, Phoenix CR strives to contribute significantly to cutting-edge healthcare solutions. Leveraging their in-depth understanding of the region’s regulatory landscape, they provide expert solutions encompassing protocol design, site selection, patient recruitment, and regulatory submissions. Clients can rely on Phoenix CR to navigate the complexities of clinical research with utmost professionalism and dedication.”
Learn more: www.phoenix-cr.com
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
January 30, 2025
MedtechDive Artificial intelligence was a topic of focus for the medical device industry in 2024. Companies including GE Healthcare, Medtronic and Dexcom touted new AI features, and others like Stryker and Quest Diagnostics added AI assets through M&A. Meanwhile, conversations about regulations and generative AI, models that are trained to create new data including images and text, dominated medtech conferences. The Food and Drug Administration recently […]
January 30, 2025
BioPharm International FDA published a final guidance on Jan. 2, 2025 for those interested in participating in the agency’s Advanced Manufacturing Technologies Designation Program, which was developed to facilitate drugs manufactured using advanced manufacturing technologies (AMTs). The guidance, Advanced Manufacturing Technologies Designation Program, is the final version of the draft document issued on Dec. 13, 2023. […]
January 30, 2025
Applied Clinical Trials Online Medable has shared new data from the Tufts Center for the Study of Drug Development (CSDD)’s PACT Consortium linking decentralized clinical trial (DCT) approaches to a higher rate in participation across multiple demographic groups. The new research shows that a more strategic implementation of DCT elements, combined with increased regulatory oversight, […]